Cure Parkinson's is a UK-based charity dedicated to finding a cure for Parkinson's disease. The organization focuses exclusively on funding research that has the potential to slow, halt, or reverse Parkinson's, with a particular emphasis on clinical trials of disease-modifying therapies. Founded in 2005, the charity has become a major force in accelerating Parkinson's research, particularly through its innovative drug repurposing approach.
An international committee of leading Parkinson's researchers that evaluates and accelerates clinical trials of disease-modifying therapies. The committee has reviewed over 200 compounds and has been instrumental in advancing numerous repurposed drugs into clinical trials for Parkinson's disease.
A systematic program to identify and advance existing drugs that may have disease-modifying potential in Parkinson's, including:
The flagship clinical trials program that has supported multiple international Phase II and III trials of repurposed drugs. This program partners with pharmaceutical companies and academic centers to rapidly test potential disease-modifying therapies.
Cure Parkinson's has been at the forefront of clinical research:
| Disease | Research Priority |
|---|---|
| Parkinson's Disease | Primary focus |
| Parkinsonism | Related conditions |
| Dementia with Lewy Bodies | Synucleinopathies |
| Progressive Supranuclear Palsy | Related disorders |
Cure Parkinson's works globally:
The organization invests in the next generation:
The study of Cure Parkinson'S has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.